Nicox secures future royalty revenue from ZERVIATE NDA in China.

Nicox’s partner, Ocumension Therapeutics, submits a New Drug Application for ZERVIATE in China ZERVIATE® approval and launch expected ...

April 14, 2023 | Friday | News
Phase 3 trial for COPD initiated by Nuance Pharma in China; First patient dosed in ENHANCE study

In August 2022, Nuance Pharma received clearance from the Center of Drug Evaluation (“CDE”) for its Investigational New Drug (“IND”...

April 10, 2023 | Monday | News
Mabwell's Nectin-4 Targeted ADC Shows Promising Clinical Data in China

Mabwell (688062.SH), an innovative biopharmaceutical company with the whole industry chain layout, announced its Nectin-4 targeted site-specific ADC asset ...

April 09, 2023 | Sunday | News
Asia Pacific Cancer Biomarkers Market Analysis

Cancer is one of the leading causes of death across Asian countries. According to a report published by Janssen Asia Pacific, in 2017, overall, there wer...

April 07, 2023 | Friday | News
Nuance Pharma Doses First Patient in China COPD Trial

Ensifentrine is a first-in-class, selective, dual inhibitor of the enzymes phosphodiesterase 3 and 4 ("PDE3" and "PDE4") combining bronchodilator and non-s...

April 07, 2023 | Friday | News
ZSFab Announces First US Clinical Use of ZSFab Cervical Interbody System for ACDF

ZSFab, Inc., a 3D-printing medical device company, is proud to announce that the ZSFab Cervical Interbody System has been successfully used in its first cl...

April 06, 2023 | Thursday | News
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA

Nefecon NDA is currently under Priority Review in China and expected to receive approval in 2H 2023- Everest Medicines (HKEX 1952.HK, "...

April 06, 2023 | Thursday | News
WuXi STA Enhances Peptide Manufacturing Capability with Addition of Large-Scale Continuous Purification System

WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), announces that it has added two 2,000 L reactors and a large-sca...

April 06, 2023 | Thursday | News
Arrowhead Pharmaceuticals Announces $30 Million Milestone Payment from GSK

GSK4532990 is being developed under the November 2021 exclusive license agreement between Arrowhead and GSK. GSK received an exclusive license to develop a...

April 04, 2023 | Tuesday | News
The World's Second Approved Biosimilars of Denosumab (MAILISHU)

MAILISHU is the world's second approved Biosimilars of Denosumab for the osteoporosis in postmenopausal women at high risk of fracture. The drug can signif...

April 03, 2023 | Monday | News
Tiens Group Attends Boao Forum for Asia Annual Conference 2023

The highly anticipated Boao Forum for Asia (BFA) Annual Conference 2023 themed "An Uncertain World: Solidarity and Cooperation for Development amid Challen...

April 03, 2023 | Monday | News
AAHRPP Accredits Two More Research Organizations, Including Another in China

The newly accredited organizations are: Allina Health System, Minneapolis, Minnesota Beijing Hospital of Traditional Chinese Medicine, Capital Medical ...

April 01, 2023 | Saturday | News
Ablaze Pharmaceuticals to Develop GPC3-Targeted Radiopharmaceutical for Liver Cancer in Greater China

The proprietary GPC3 targeting peptide is being licensed from RayzeBio pursuant to an existing license agreement. Upon in-license of product candidates by ...

March 31, 2023 | Friday | News
Scivita Medical enters into Strategic Agreement with Boston Scientific in China

Under Scivita Medical's comprehensive product lineup of reusable endoscopes, single-use videoscopes and related systems and equipment, this cooperation fur...

March 30, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close